NEW YORK, June 7 – Bruker Daltonics will exclusively license MALDI-TOF mass spectrometry technology from Indiana University, and grant Applied Biosystems a sublicense to the technology, the companies said Thursday.
The patented technology covers space-velocity correlation focusing (SVCF), or delayed extraction (DE), a technique related to MALDI-TOF mass spectrometry. SVCF technology improves the accuracy and sensitivity mass spectrometry analysis, according to the companies.
Bruker Daltonics is licensing the technology from Indiana University’s Advanced Research and Technology Institute, the technology-transfer arm of the university. Applied Biosystems will pay Bruker multi-year royalty payments for its sublicense to the technology. Bruker Daltonics and Applied Biosystems have cross-licensed each other’s technology related to SVCF.“We believe that it is in the best interest of our customers in this field to jointly promote the MALDI-TOF market via a licensing program," said Frank Laukien, CEO of Bruker Daltonics, and Michael Hunkapiller, president of Applied Biosystems, in a statement.